Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure

Mov Disord. 2007 Aug 15;22(11):1678-9. doi: 10.1002/mds.21579.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Gynecomastia / chemically induced*
  • Heart Failure / complications
  • Heart Failure / drug therapy
  • Humans
  • Male
  • Mineralocorticoid Receptor Antagonists / adverse effects*
  • Movement Disorders / etiology*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy
  • Spironolactone / adverse effects*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone